SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-323898
Filing Date
2018-11-09
Accepted
2018-11-09 17:15:02
Documents
7
Period of Report
2018-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d652181d8k.htm 8-K 19276
2 EX-1.1 d652181dex11.htm EX-1.1 196358
3 EX-5.1 d652181dex51.htm EX-5.1 6113
4 EX-99.1 d652181dex991.htm EX-99.1 7363
5 EX-99.2 d652181dex992.htm EX-99.2 7818
6 GRAPHIC g652181g83x59.jpg GRAPHIC 3339
7 GRAPHIC g652181g84g44.jpg GRAPHIC 3014
  Complete submission text file 0001193125-18-323898.txt   247422
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 181174011
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1